English | 繁體

Search in the results

UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor Journal article
Wang, Mengjiao, Wan, Quan, Wang, Chenglv, Jing, Qianyu, Nie, Yujie, Zhang, Xiangyan, Chen, Xin, Yang, De, Pan, Runsang, Li, Linzhao, Zhu, Lan, Gui, Huan, Chen, Shuanghui, Deng, Yuezhen, Chen, Tao, Nie, Yingjie. Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor[J]. Molecular and Cellular Biochemistry, 2024.
Authors:  Wang, Mengjiao;  Wan, Quan;  Wang, Chenglv;  Jing, Qianyu;  Nie, Yujie; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.5/3.3 | Submit date：2024/05/16
Combination Immunotherapy  Hmgn1  Immunosuppression  R848  Α-tnfr2  
Combination strategies for first-line treatment of patients with unresectable hepatocellular carcinoma: prospect of natural products Other
2024-01-01
Authors:  ZHANG, Lele;  LU, Jinjian
Favorite | TC[WOS]:4 TC[Scopus]:4 | Submit date：2024/02/22
Combination Strategies  Immunotherapy  Natural Products  Pd-1/pd-l1  Unresectable Hepatocellular Carcinoma  
Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy Journal article
Li, Qiuxia, Liu, Xing, Yan, Chunmei, Zhao, Bolin, Zhao, Yuxin, Yang, Lu, Shi, Mingyi, Yu, Hua, Li, Xiaofang, Luo, Kaipei. Polysaccharide-Based Stimulus-Responsive Nanomedicines for Combination Cancer Immunotherapy[J]. Small, 2023, 19(23), 2206211.
Authors:  Li, Qiuxia;  Liu, Xing;  Yan, Chunmei;  Zhao, Bolin;  Zhao, Yuxin; et al.
Favorite | TC[WOS]:27 TC[Scopus]:29  IF:13.0/13.5 | Submit date：2023/07/20
Anticancer Efficacy  Combination Cancer Immunotherapy  Drug Delivery  Polysaccharide  Stimulus-responsive Nanomedicines  
Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms Journal article
Huang,Mu Yang, Jiang,Xiao Ming, Wang,Bing Lin, Sun,Yang, Lu,Jin Jian. Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms[J]. Pharmacology and Therapeutics, 2021, 219, 107694.
Authors:  Huang,Mu Yang;  Jiang,Xiao Ming;  Wang,Bing Lin;  Sun,Yang;  Lu,Jin Jian
Favorite | TC[WOS]:88 TC[Scopus]:90  IF:12.0/12.5 | Submit date：2021/03/02
Challenge  Combination Therapy  Immunotherapy  Mechanism  Nsclc  Pd-1/pd-l1  
Combination strategies using EGFR-TKi in NSCLC therapy: Learning from the gap between pre-clinical results and clinical outcomes Journal article
Yang,Zheng, Tam,Kin Yip. Combination strategies using EGFR-TKi in NSCLC therapy: Learning from the gap between pre-clinical results and clinical outcomes[J]. International Journal of Biological Sciences, 2018, 14(2), 204-216.
Authors:  Yang,Zheng;  Tam,Kin Yip
Favorite | TC[WOS]:74 TC[Scopus]:81  IF:8.2/8.3 | Submit date：2021/03/04
Chemotherapy  Combination  Egfr-tki  Immunotherapy  Nsclc  Targeted Therapy  
Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes Journal article
Yang, Zheng, Tam, Kin Yip. Combination Strategies Using EGFR-TKi in NSCLC Therapy: Learning from the Gap between Pre-Clinical Results and Clinical Outcomes[J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14(2), 204-216.
Authors:  Yang, Zheng;  Tam, Kin Yip
Favorite | TC[WOS]:74 TC[Scopus]:81  IF:8.2/8.3 | Submit date：2018/10/30
Combination  Egfr-tki  Nsclc  Chemotherapy  Targeted Therapy  Immunotherapy